-
Forbion Wins ‘VC firm of the Year’ at the LSX’s LifeStars Awards
November 20, 2019Forbion, a leading European life science venture capital firm, today announced that it has won ‘VC firm of the...
0 -
Forbion Portfolio Company, AM-Pharma raises €116m
July 16, 2019Forbion Portfolio Company, AM-Pharma raises €116m to conduct Pivotal Phase III Trial of recAP in acute kidney injury. Please...
-
Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk
December 17, 2018Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for Dyslipidaemia. Naarden,...
-
Forbion Appoints Dr. Carlo Incerti as Operating Partner
November 29, 2018Naarden, The Netherlands, and Munich, Germany, 29 November 2018 – Forbion, a leading European life science venture capital firm,...
-
Forbion Co-leads $54m Series A Financing in newly formed Gotham Therapeutics
October 11, 2018Naarden, The Netherlands, and Munich, German, 10 October 2018 – Forbion, a leading European life sciences venture capital firm,...
-
Forbion participates in £29M Series B Financing of Enterprise Therapeutics to Advance its Ion Channel Modulators for the treatment of Cystic-fibrosis, COPD and severe asthma
April 12, 2018Press Release Forbion participates in £29M Series B Financing of Enterprise Therapeutics to Advance its Ion Channel Modulators for...
-
Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (USD 1.1 billion)
March 16, 2018Press Release Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (USD 1.1 billion)...
-
Forbion leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases
March 13, 2018Press Release Forbion leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Systemic RORγt...
-
Forbion invests in Prexton Therapeutics’ EUR 29 million Series B financing
February 7, 2017Forbion invests in Prexton Therapeutics’ EUR 29 million (USD 31 million) Series B financing Forbion & Seroba co-led funding,...
-
Forbion’s portfolio company Akarna Therapeutics Ltd acquired by Allergan plc
September 21, 2016Forbion’s portfolio company Akarna Therapeutics Ltd acquired by Allergan plc Allergan acquires Akarna to develop highly differentiated treatments for...
Forbion highlight
